• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体-α抑制肝癌发生并建立性别特异性基因表达。

Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression.

作者信息

O'Brien Mara H, Pitot Henry C, Chung Sang-Hyuk, Lambert Paul F, Drinkwater Norman R, Bilger Andrea

机构信息

Department of Craniofacial Sciences, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA.

McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI 53705, USA.

出版信息

Cancers (Basel). 2021 May 13;13(10):2355. doi: 10.3390/cancers13102355.

DOI:10.3390/cancers13102355
PMID:34068249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8153146/
Abstract

Estrogen protects females from hepatocellular carcinoma (HCC). To determine whether this protection is mediated by classic estrogen receptors, we tested HCC susceptibility in estrogen receptor-deficient mice. In contrast to a previous study, we found that diethylnitrosamine induces hepatocarcinogenesis to a significantly greater extent when females lack , which encodes Estrogen Receptor-α. Relative to wild-type littermates, knockout females developed 9-fold more tumors. Deficiency of , which encodes Estrogen Receptor-β, did not affect liver carcinogenesis in females. Using microarrays and QPCR to examine estrogen receptor effects on hepatic gene expression patterns, we found that germline deficiency resulted in the masculinization of gene expression in the female liver. Six of the most dysregulated genes have previously been implicated in HCC. In contrast, deletion specifically in hepatocytes of conditional null female mice (in which Cre was expressed from the albumin promoter) resulted in the maintenance of female-specific liver gene expression. Wild-type adult females lacking ovarian estrogen due to ovariectomy, which is known to make females susceptible to HCC, also maintained female-specific expression in the liver of females. These studies indicate that mediates liver cancer risk, and its control of sex-specific liver gene expression involves cells other than hepatocytes.

摘要

雌激素可保护女性免受肝细胞癌(HCC)的侵害。为了确定这种保护作用是否由经典雌激素受体介导,我们检测了雌激素受体缺陷小鼠的HCC易感性。与之前的一项研究相反,我们发现当雌性小鼠缺乏编码雌激素受体α的 时,二乙基亚硝胺诱导肝癌发生的程度明显更高。相对于野生型同窝小鼠, 基因敲除的雌性小鼠产生的肿瘤多9倍。编码雌激素受体β的 基因缺失对雌性小鼠的肝癌发生没有影响。我们使用微阵列和定量聚合酶链反应来检测雌激素受体对肝脏基因表达模式的影响,发现种系 基因缺陷导致雌性肝脏基因表达男性化。其中六个失调最严重的基因此前已被证明与HCC有关。相比之下,在条件性基因敲除雌性小鼠(其中Cre由白蛋白启动子表达)的肝细胞中特异性缺失 ,可维持雌性特异性肝脏基因表达。因卵巢切除而缺乏卵巢雌激素的野生型成年雌性小鼠(已知这会使雌性易患HCC),其肝脏中也维持了雌性特异性表达。这些研究表明, 介导肝癌风险,其对性别特异性肝脏基因表达的控制涉及肝细胞以外的细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/158d52a24cb1/cancers-13-02355-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/532530465ce4/cancers-13-02355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/4265b984115c/cancers-13-02355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/c16407299a15/cancers-13-02355-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/e29419b7e991/cancers-13-02355-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/158d52a24cb1/cancers-13-02355-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/532530465ce4/cancers-13-02355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/4265b984115c/cancers-13-02355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/c16407299a15/cancers-13-02355-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/e29419b7e991/cancers-13-02355-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d212/8153146/158d52a24cb1/cancers-13-02355-g005.jpg

相似文献

1
Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression.雌激素受体-α抑制肝癌发生并建立性别特异性基因表达。
Cancers (Basel). 2021 May 13;13(10):2355. doi: 10.3390/cancers13102355.
2
Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.雌激素受体-1(Esr1)和-2(Esr2)调节雄性小鼠临床实验性变应性脑脊髓炎的严重程度。
Am J Pathol. 2004 Jun;164(6):1915-24. doi: 10.1016/S0002-9440(10)63752-2.
3
Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma.异常的 DNA 甲基化抑制卵巢子宫内膜异位症中雌激素受体 1(ESR1)的表达。
J Ovarian Res. 2019 Feb 6;12(1):14. doi: 10.1186/s13048-019-0489-1.
4
The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility.这种小突变可抑制二乙基亚硝胺诱导的小鼠肝癌发生,并消除遗传和激素对易感性的调节作用。
Carcinogenesis. 2001 Nov;22(11):1853-62. doi: 10.1093/carcin/22.11.1853.
5
Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2.雌激素受体1和2对诱导型一氧化氮合酶基因的差异调节
J Endocrinol. 2008 Nov;199(2):267-73. doi: 10.1677/JOE-07-0292. Epub 2008 Aug 27.
6
Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause.性激素结合球蛋白可抑制绝经后非酒精性脂肪性肝病引发的肝癌发生。
Carcinogenesis. 2019 Aug 22;40(8):1031-1041. doi: 10.1093/carcin/bgz107.
7
Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation.雌激素受体在应激行为反应和精神运动激活中的性别特异性参与。
Front Psychiatry. 2019 Feb 26;10:81. doi: 10.3389/fpsyt.2019.00081. eCollection 2019.
8
Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.雌激素激活 G 蛋白偶联雌激素受体 1 调节磷酯酰肌醇 3-激酶和 mTOR 信号通路促进斑马鱼肝脏生长和人肝细胞增殖。
Gastroenterology. 2019 May;156(6):1788-1804.e13. doi: 10.1053/j.gastro.2019.01.010. Epub 2019 Jan 12.
9
Activation of estrogen receptor ESR1 and ESR2 induces proliferation of the human testicular embryonal carcinoma NT2/D1 cells.雌激素受体 ESR1 和 ESR2 的激活可诱导人睾丸胚胎癌细胞 NT2/D1 的增殖。
Mol Cell Endocrinol. 2022 Aug 20;554:111708. doi: 10.1016/j.mce.2022.111708. Epub 2022 Jul 2.
10
Methylation patterns of estrogen receptor α promoter correlate with estrogen receptor α expression and clinicopathological factors in hepatocellular carcinoma.雌激素受体α启动子的甲基化模式与肝细胞癌中雌激素受体α的表达及临床病理因素相关。
Exp Biol Med (Maywood). 2014 Jul;239(7):883-890. doi: 10.1177/1535370214536651. Epub 2014 Jun 17.

引用本文的文献

1
Sex based relative expression of estrogen receptors and tumor necrosis factor-alpha in liver affects hepatitis C virus viral pathogenesis.肝脏中雌激素受体和肿瘤坏死因子-α基于性别的相对表达影响丙型肝炎病毒的发病机制。
World J Gastroenterol. 2025 Aug 28;31(32):104277. doi: 10.3748/wjg.v31.i32.104277.
2
Non-canonical activation of MAPK signaling by the lncRNA ASH1L-AS1-encoded microprotein APPLE through inhibition of PP1/PP2A-mediated ERK1/2 dephosphorylation in hepatocellular carcinoma.在肝细胞癌中,长链非编码RNA ASH1L-AS1编码的微小蛋白APPLE通过抑制PP1/PP2A介导的ERK1/2去磷酸化对MAPK信号通路进行非经典激活。
J Exp Clin Cancer Res. 2025 Jul 11;44(1):200. doi: 10.1186/s13046-025-03465-w.
3

本文引用的文献

1
Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.综合生物信息学分析鉴定 MTHFD1L 为肝癌潜在的生物标志物,并与肿瘤免疫浸润相关。
Biosci Rep. 2021 Feb 26;41(2). doi: 10.1042/BSR20202063.
2
Integrative analysis of the characteristics of lipid metabolism-related genes as prognostic prediction markers for hepatocellular carcinoma.脂质代谢相关基因特征的综合分析作为肝细胞癌的预后预测标志物。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):116-126. doi: 10.26355/eurrev_202101_24355.
3
Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular Carcinoma.
Elucidating the Anti-Diabetic Mechanisms of Mushroom Chaga () by Integrating LC-MS, Network Pharmacology, Molecular Docking, and Bioinformatics.
通过整合液相色谱-质谱联用技术、网络药理学、分子对接和生物信息学阐明桦褐孔菌的抗糖尿病机制
Int J Mol Sci. 2025 May 28;26(11):5202. doi: 10.3390/ijms26115202.
4
Strain- and sex-dependent variability in hepatic microcirculation and liver function in mice.小鼠肝脏微循环和肝功能的应变及性别依赖性变异性。
World J Gastroenterol. 2025 Apr 21;31(15):101058. doi: 10.3748/wjg.v31.i15.101058.
5
Estrogen receptor α suppresses hepatocellular carcinoma by restricting M2 macrophage infiltration through the YAP-CCL2 axis.雌激素受体α通过YAP-CCL2轴限制M2巨噬细胞浸润来抑制肝细胞癌。
BMC Cancer. 2025 Mar 27;25(1):550. doi: 10.1186/s12885-025-13676-1.
6
Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review.雌激素和雌激素受体在消化系统癌症中的复杂作用:系统评价。
Cancer Biol Med. 2024 Oct 30;21(10):898-915. doi: 10.20892/j.issn.2095-3941.2024.0224.
7
Cell-specific AHR-driven differential gene expression in the mouse liver cell following acute TCDD exposure.急性 TCDD 暴露后小鼠肝实质细胞中 AHR 驱动的细胞特异性差异基因表达。
BMC Genomics. 2024 Aug 28;25(1):809. doi: 10.1186/s12864-024-10730-3.
8
The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes.肌肉减少症对肝细胞癌治疗结果的负面影响。
Cancers (Basel). 2024 Jun 24;16(13):2315. doi: 10.3390/cancers16132315.
9
The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma.孤儿核受体 NR2E3 的缺失通过表观遗传失调增强 Wnt/β-catenin 信号通路,从而增强肝癌中 Sp1-β catenin-p300 相互作用。
Adv Sci (Weinh). 2024 Aug;11(29):e2308539. doi: 10.1002/advs.202308539. Epub 2024 May 24.
10
Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.性别对肝细胞癌肝移植结局的影响:中国一项多中心队列研究
Cancer Biol Med. 2024 Feb 28;21(4):347-62. doi: 10.20892/j.issn.2095-3941.2023.0453.
lncRNA相关ceRNA网络的综合分析揭示了肝细胞癌的潜在生物标志物。
J Comput Biol. 2021 Mar;28(3):330-344. doi: 10.1089/cmb.2019.0250. Epub 2020 Nov 4.
4
Arbutin suppresses osteosarcoma progression via miR-338-3p/MTHFD1L and inactivation of the AKT/mTOR pathway.熊果苷通过 miR-338-3p/MTHFD1L 抑制骨肉瘤的进展,并抑制 AKT/mTOR 通路的激活。
FEBS Open Bio. 2021 Jan;11(1):289-299. doi: 10.1002/2211-5463.13024. Epub 2020 Dec 3.
5
miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.miR-9-5p 通过靶向 ESR1 促进肝癌细胞的增殖、迁移和侵袭。
Mol Cell Biochem. 2021 Feb;476(2):575-583. doi: 10.1007/s11010-020-03927-z. Epub 2020 Oct 27.
6
Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma.基于免疫相关基因的肝癌患者预后指标的探索。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20194240.
7
Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications.三叶因子在癌症中的探索:诊断和治疗意义。
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188362. doi: 10.1016/j.bbcan.2020.188362. Epub 2020 Apr 13.
8
miR-939-3p promotes epithelial-mesenchymal transition and may be used as a prognostic marker in hepatocellular carcinoma.微小RNA-939-3p促进上皮-间质转化,可作为肝细胞癌的预后标志物。
Oncol Lett. 2020 Apr;19(4):2727-2732. doi: 10.3892/ol.2020.11361. Epub 2020 Jan 30.
9
Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.通过生物信息学分析基于肝细胞癌表达谱鉴定关键基因。
PeerJ. 2019 Aug 8;7:e7436. doi: 10.7717/peerj.7436. eCollection 2019.
10
Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma.成簇微小RNA hsa-miR-221-3p/hsa-miR-222-3p及其靶向基因可能是肝细胞癌的预后预测指标。
J Cancer. 2019 Jun 2;10(11):2520-2533. doi: 10.7150/jca.29207. eCollection 2019.